These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24825187)
1. Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells. Berglund E; Akcakaya P; Berglund D; Karlsson F; Vukojević V; Lee L; Bogdanović D; Lui WO; Larsson C; Zedenius J; Fröbom R; Bränström R Exp Cell Res; 2014 Aug; 326(2):315-25. PubMed ID: 24825187 [TBL] [Abstract][Full Text] [Related]
2. DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors. Simon S; Grabellus F; Ferrera L; Galietta L; Schwindenhammer B; Mühlenberg T; Taeger G; Eilers G; Treckmann J; Breitenbuecher F; Schuler M; Taguchi T; Fletcher JA; Bauer S Cancer Res; 2013 Jun; 73(12):3661-70. PubMed ID: 23576565 [TBL] [Abstract][Full Text] [Related]
3. Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells Fröbom R; Sellberg F; Xu C; Zhao A; Larsson C; Lui WO; Nilsson IL; Berglund E; Bränström R Anticancer Res; 2019 Jul; 39(7):3433-3442. PubMed ID: 31262867 [TBL] [Abstract][Full Text] [Related]
4. RACK1 overexpression is linked to acquired imatinib resistance in gastrointestinal stromal tumor. Gao X; Xue A; Fang Y; Shu P; Ling J; Hou Y; Shen K; Qin J; Sun Y; Qin X Oncotarget; 2016 Mar; 7(12):14300-9. PubMed ID: 26893362 [TBL] [Abstract][Full Text] [Related]
5. Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines. Noma K; Naomoto Y; Gunduz M; Matsuoka J; Yamatsuji T; Shirakawa Y; Nobuhisa T; Okawa T; Takaoka M; Tomono Y; Hiroyuki O; Gunduz E; Tanaka N Oncol Rep; 2005 Sep; 14(3):645-50. PubMed ID: 16077968 [TBL] [Abstract][Full Text] [Related]
6. Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells. Dong Y; Liang C; Zhang B; Ma J; He X; Chen S; Zhang X; Chen W Cancer Lett; 2015 May; 361(1):137-46. PubMed ID: 25737303 [TBL] [Abstract][Full Text] [Related]
7. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M; Wang ZF; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013 [TBL] [Abstract][Full Text] [Related]
8. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors. Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018 [TBL] [Abstract][Full Text] [Related]
9. DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Hwang DG; Qian X; Hornick JL Am J Clin Pathol; 2011 Mar; 135(3):448-53. PubMed ID: 21350101 [TBL] [Abstract][Full Text] [Related]
10. Orai1 mediates tumor-promoting store-operated Ca Wang L; Hao J; Zhang Y; Yang Z; Cao Y; Lu W; Shu Y; Jiang L; Hu Y; Lv W; Liu Y; Dong P Tumour Biol; 2017 Feb; 39(2):1010428317691426. PubMed ID: 28231736 [TBL] [Abstract][Full Text] [Related]
11. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology. Sui XL; Wang H; Sun XW Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337 [TBL] [Abstract][Full Text] [Related]
12. Inhibition effect of Peg-IFNα-2b and Imatinib alone or combination on imatinib-resistant gastrointestinal stromal tumors cell lines. Zhang LY; Huang JS; Pi ZM; Yu MY Int J Clin Exp Pathol; 2015; 8(9):11340-7. PubMed ID: 26617858 [TBL] [Abstract][Full Text] [Related]
13. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors. Jang BG; Lee HE; Kim WH Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012 [TBL] [Abstract][Full Text] [Related]
14. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323 [TBL] [Abstract][Full Text] [Related]
15. KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway. Bauer S; Duensing A; Demetri GD; Fletcher JA Oncogene; 2007 Nov; 26(54):7560-8. PubMed ID: 17546049 [TBL] [Abstract][Full Text] [Related]
16. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it. Lee CH; Liang CW; Espinosa I Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677 [TBL] [Abstract][Full Text] [Related]
17. Utility of DOG1 Immunomarker in Fine Needle Aspirates of Gastrointestinal Stromal Tumor. Kakkar A; Mathur SR; Jain D; Iyer VK; Nalwa A; Sharma MC Acta Cytol; 2015; 59(1):61-7. PubMed ID: 25632981 [TBL] [Abstract][Full Text] [Related]
18. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. Liu W; Lu M; Liu B; Huang Y; Wang K Cancer Lett; 2012 Dec; 326(1):41-51. PubMed ID: 22820160 [TBL] [Abstract][Full Text] [Related]
20. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]